SWM
AZN icon

Sendero Wealth Management’s AstraZeneca AZN Stock Holding History

Sendero Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,736
Closed -$1.82M – 153
2023
Q2 		$1.82M Sell
12,736
-945
-7% -$139K 0.4% 53
2023
Q1 		$1.9M Buy
13,681
+1,109
+9% +$149K 0.58% 38
2022
Q4 		$1.7M Buy
12,572
+1,069
+9% +$134K 0.61% 30
2022
Q3 		$1.26M Buy
11,503
+643
+6% +$81.6K 0.53% 29
2022
Q2 		$1.44M Buy
+10,860
New +$1.42M 1.38% 19

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sendero Wealth Management's AZN Position: Q3 2023 in Review

Sendero Wealth Management sold out of AstraZeneca (AZN) in Q3 2023, closing a stake of 12,736 shares — an estimated $1.82M sold.

Sendero Wealth Management first reported a position in AZN in Q2 2022 and held it in 5 quarters. The position peaked at $1.9M in Q1 2023. 1,074 funds tracked by Wall St. Rank hold AZN as of Q3 2023.

  • Sendero Wealth Management reported no remaining AstraZeneca position as of Q3 2023 after selling out during the quarter.
  • Sendero Wealth Management sold 12,736 AstraZeneca shares in Q3 2023, an estimated $1.82M.
  • Sendero Wealth Management first reported a position in AstraZeneca in Q2 2022 and held it in 5 quarters.
  • Sendero Wealth Management's AstraZeneca position peaked at $1.9M in Q1 2023.
  • 1,074 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2023.

Based on Sendero Wealth Management's 13F filing for Q3 2023, filed 10 Oct 2023.